Ignite Creation Date:
2024-05-06 @ 1:46 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01892345
Status:
TERMINATED
Last Update Posted:
2019-06-26
First Post:
2013-06-20
Brief Title:
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO PREVENT Study
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-17
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-20
First Submit QC Date:
July 1 2013
Study First Post Date:
2013-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-07
Last Update Post Date:
2019-06-26
Last Update Post Date Type:
ACTUAL